Project: A new medical device gel that reduces chronic inflammation and restores oral soft tissue health

Acronym	OralG (Reference Number: 12432)
Duration	01/09/2018
Project Topic	The aim of the project is to develop a medical device (MD) based on a new patented synthetic bifunctional peptide acting as a non-antibiotic, anti inflammatory wound healing agent for protections against severe periodontitis and peri-implantitis. Unmet medical needs regarding oral soft tissue management are specifically targeted thanks to a new gel against inflammation, avoiding loss of jaw-bone and painful regenerative procedures for patients and costs for both patients and public stakeholders.
Network	Eurostars 2
Call	Eurostars Cut–off 9

Project partner

Number	Name	Role	Country
1	REGENTIS-PHARMA	Coordinator	France
2	CORTICALIS AS	Partner	Norway
3	UNIVERSITY OF OSLO	Partner	Norway